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Summary
Objectives: To study the effects exerted by two antioxidants, N-monomethyl-L-arginine (L-NMMA), as an inhibitor of nitric oxide (NO)
synthesis, and N-acetylcysteine (NAC), a reactive oxygen species (ROS) scavenger, on the expression of the major growth factor involved
in cartilage repair, TGF-, under the three isoforms 1, 2 and 3, and the receptors I and II of this factor, using lipopolysaccharide
(LPS)-treated human chondrocytes in culture.
Methods: Suspension cultures of human chondrocytes derived from the knee of osteoarthritic patients were treated for 48 h with
lipopolysaccharide (LPS) (10 g/ml), L-NMMA (0.5 mM) or NAC (1 mM). Nitrite levels were assayed on the culture media using the Griess
spectrophotometric method. After total RNA extraction, the expression of inducible NO synthase (iNOS), TGF-1, TGF-2, TGF-3, TGF-
receptors I and II, was determined by semi-quantitative polymerase chain-reaction (RT-PCR).
Results: LPS induced a dramatic increase of both NO production and iNOS mRNA level. The addition of L-NMMA (0.5 mM) abolished NO
production without affecting iNOS mRNA levels. In contrast NAC (1 mM) strongly synergized with LPS to stimulate NO synthesis. LPS
treatment did not significantly alter TGF-1 expression whereas L-NMMA inhibited its production. TGF-2 mRNA level was decreased by
LPS and was not changed in the presence of L-NMMA. On the other hand, NAC was capable of counteracting the LPS-induced inhibition
of TGF-2 expression. TGF3 mRNA level was markedly reduced by LPS alone, or with both L-NMMA and NAC. Finally, the expression of
TGF-RI was slightly increased in the presence of combined LPS and L-NMMA or NAC whereas that of TGF-RII was reduced in the same
conditions.
Conclusions: The modulation of TGF- system was found to be differentially controlled by NO and ROS productions. Indeed, the control
exerted on TGF- expression varied according to the isoform: TGF-1 mRNA level depends on NO whereas that of TGF-2 is regulated by
ROS and TGF-3 seems to be unaffected by both of them. The expression of TGF- receptors appeared to be modulated by NO and ROS
levels. The relevance of the present findings to osteoarthritis (OA) physiopathology and the potential use of antioxidant therapy to treat this
disease are discussed. © 2001 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Progressive loss of cartilage is the characteristic feature of
joint diseases such as osteoarthritis (OA) and rheumatoid
arthritis (RA). In late stages of the pathology, this may lead
to joint failure and implantation of prothesis remains today
the only clinical treatment possible. Therefore, chondropro-
tection of the cartilage is one of the most important and
attractive goals to achieve in this medical field.
It is now recognized that the homeostasis of cartilage
results from the balance between its anabolic and its
catabolic rates. Depletion of cartilage occurs in OA through
both breakdown of the matrix and reduced synthesis of its
macromolecular components. Interleukin-1 (IL-1) and
tumor necrosis factor- (TNF-) have been shown to be
implicated in these mechanisms since they are present in344excess in affected joints and are capable of degrading the
cartilaginous matrix while inhibiting its synthesis1–3. On the
other hand, local growth factors produced by chondrocytes,
such as transforming growth factor- (TGF-), can counter-
act the deleterious effects of IL-1 and TNF- through
stimulation of matrix synthesis and inhibition of metallopro-
tease expression4,6. TGF-, which is expressed under its
three isoforms (1, 2 and 3) in cartilage, appears as one
of the major element in the repair potential of the tissue7–11.
The dramatic decrease of TGF- receptor II expression by
chondrocytes at the stage of fibrillated cartilage in the
experimental rabbit OA model12 and the appearance of
OA-like lesions in transgenic mice expressing nonfunc-
tional receptor II13 strongly suggest that the TGF- system
takes a great part in the repair potential of articular carti-
lage14. Thus, the mechanisms which control the expression
of TGF- systems in articular chondrocytes submitted to
physiological or pathological situations merit particular
attention, in view of future therapeutic approaches aimed at
cartilage chondroprotection.
In this regard, it is of great interest to determine what
could be the effects exerted by nitric oxide (NO) and
reactive oxygen species (ROS) on the expression of TGF-Received 7 September 2001.
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synthesized during metabolism of L-arginine to NO−2 or
NO−3 15,16 and is produced in large amounts by articular
chondrocytes in response to IL-117–19. Several reports
have demonstrated that NO was involved, at least partially,
in the IL-1-induced suppressive effect on cartilage prote-
oglycan synthesis through inhibition of the core protein
synthesis20–23. It also mediates the IL-1 stimulative effect
exerted on gene expression of matrix metalloproteinases
in rabbit articular chondrocytes24. Indeed, it has been
reported that the concentration of nitrite, which represents
the local NO production, is increased in synovial fluid and
sera from patients with inflammatory or degenerative dis-
eases such as OA and RA25,26. Accumulating evidence
also suggests that ROS are not only injurious by-products
of cellular metabolism but also essential participants in cell
signaling and regulation in most cell types, including articu-
lar chondrocytes (review in 27). It is known that ROS are
active on various components of the cartilage matrix, such
as hyaluronic acid28, proteoglycans and collagen29,30.
They may also influence articular chondrocyte growth31,
induce membrane damage32 and reduce their metabolic
pathways for energy production33,34. It has been revealed
that free radicals are involved in arthritic conditions35.
Among the ROS produced by chondrocytes, hydrogen
peroxide is increased by cytokines such as IL-1, TNF- and
IFN-36–41 and the chondrocytes have been shown to be
damaged by hydrogen peroxide42. Superoxide (O−2 ) and
nitric oxide (NO) can react to form the most potent perox-
ynitrite anion43. Potentially toxic levels of peroxynitrite can
be achieved in joint tissues under conditions in which
superoxide (O−2 ) and NO production are simultaneously
stimulated by IL-113. As far as we know, the hypothesis that
NO and ROS might participate in the control mechanisms
of cytokine and growth factor expression by articular
chondrocytes has not yet deserved much attention and
only little information is available about the sensitivity of
TGF- system to these active oxygen species44. The
hypothesis gains strong support from the finding that the
activity of nuclear transcription factors, such as NF-B and
AP-1, which are involved in the transcription of several
genes implicated in arthritic situations, is differentially
modulated by ROS45. In order to get insights into the roles
played by these species in the physiological and pathologi-
cal metabolism of cartilage cells, we have investigated here
the expression levels of TGF- isoforms and TGF- recep-
tors I and II in human articular chondrocytes under LPS
activation and in the presence of inhibitors of NO and ROS.REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION
(RT-PCR)
Total RNA was extracted by the guanidium thiocyanate-
phenol-chloroform method. Cells (3.106) were lysed using
TRI REAGENT (Sigma-Aldrich, Bornem, Belgium) and the
samples were processed following the manufacturer’s pro-
tocol. RNA (3 g) were transcribed in a volume of 50 l
containing 10 l of 5× First Strand Buffer, 20 M oligo
d(T)16, 1 l of Recombinant Ribonuclease Inhibitor RNA-
seOUT (40 units/l), 3 l of dNTPs (10 mM each) and 1 l
of Monoley Murine Leukaemia virus (M-MLV) (200 units/l)
(Life Technologies, Gibco, BRL) for 15 min at 42°C and
5 min at 99°C. PCR was performed with 3 l of cDNA inMaterials and methods
CULTURE OF HUMAN CHONDROCYTES
Cartilage samples were obtained from the knees of eight
donors shortly after death (four males and four females)
with the mean age of 49 (47–52) years old. They were
dissected from superficial and medium layers, avoiding the
calcified zone. Femoral and patellar articular surfaces were
evaluated for the severity of the macroscopic lesions, using
a personal scale of four grades: 0, normal white cartilage
on all area examined; I, presence of yellow-gray area with
some superficial fibrillations on one or more articular sur-
faces; II, irregular surface with deep fibrillations on one or
more articular surfaces; III, ulcers penetrating to subchon-
dral bone on one or more articular surfaces. Three out of
the five cartilage samples collected showed lesion of gradeIII and two cartilage samples had lesion of grade I. Each
culture was run with chondrocytes from a single donor.
Chondrocytes were released by sequential enzymatic
digestion, using hyaluronidase, pronase and collagenase
(10 ml enzyme solution per 3 g of cartilage). The cartilage
fragments were first treated (30 min, 37°C, 200 rpm) with
hyaluronidase (Sigma-Aldrich, Bornem, Belgium) pre-
viously dissolved (0.5 mg/ml) in Dulbecco’s modified
Eagle’s Medium supplemented with penicillin (100 U/ml)
and streptomycin (0.1 mg/ml) (DMEM; Biowhittaker,
Brussels, Belgium). The fragments were then treated (1 h,
37°C, 200 rpm) with pronase solution (Merck-Belgolabo,
Overijse, Belgium) (1 mg/ml in DMEM). Finally, they were
incubated (20 h, 37°C, 200 rpm) with collagenase solution
(Sigma-Aldrich, Bornem, Belgium) (1 mg/ml in DMEM
containing 1% Ultroser G (Life Technologies, Merlbeke,
Belgium). The cells were incubated at the density of
1.106/ml in 1 ml of DMEM without red phenol (Biowhittaker,
Brussels, Belgium) supplemented with 10 mM HEPES,
penicillin (100 U/ml), streptomycin (0.1 mg/ml) and 1% of
ITS+ (ICN, Doornveld, Belgium). ITS+ is a culture supple-
ment containing 0.625 mg of insulin, 0.625 mg of transfer-
rin, 0.625 g of selenious acid, 125 mg of bovine serum
albumin (BSA) and 0.535 mg of linoleic acid/ml. The cells
were then maintained in culture medium for 48 h in order to
eliminate the potential influence of drug treatment pre-
viously taken by the donors. They were then seeded in
15-ml polypropylene Falcon tubes and maintained under
agitation on a gyratory shaker (100 rpm) in a 95% air/5%
CO2 atmosphere. Chondrocytes were cultured for 48 h in
the absence or in the presence of LPS (10 g/ml, serotype
026:B6; Sigma-Aldrich, Bornem, Belgium) and with or with-
out L-NMMA (0.5 mM; Calbiochem, San Diego, U.S.A.) or
NAC (1 mM; Sigma-Aldrich, Bornem, Belgium). Cells and
supernatant were then separated by centrifugation
(1000 rpm; 5 min).NITRIC OXIDE ASSAY
NO production was determined by quantifying nitrite in
conditioned medium using spectrophotometric method
based on the Griess reaction. Briefly, 150 l of conditioned
culture medium or sodium nitrite (NaNO2) standard dilu-
tions were mixed with 100 l of Griess reagent (0.5%
sulfanilamide, 0.05% naphtylethylenediamine dihydrochlo-
ride, 2.5% H3PO4) and incubated for 5 min at 37°C. The
limit of detection was 2 M of nitrite. Before adding the
Griess reaction, nitrate was converted to nitrite by treating
sample with nitrate reductase (0.2 U/ml, Roche, Bruxelles,
Belgium). The absorption was recorded at 540 nm.
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units/l), 1 l of dNTPs (10 mM each), 1 l of 50 mM MgCl2
and 20 pM of each primer (Life Technologies, Gibco, BRL).
The following amplification protocol was used: 1 min at
95°C; 1 min at 55°C; 1 min at 72°C. The primer sequences
are listed in Table I. PCR amplification for Glyceraldehyde
3-Phosphate dehydrogenase (GAPDH) was performed as
an internal control for the relative amounts of templates.
PCR products were analysed in 2% agarose gels, after
staining with ethidium bromide. Densities of the band were
quantified using ImageQuant Software and the relative
expression of messengers studied was calculated as rela-
tive ratio to GAPDH. After increasing number of PCR
cycles, a plot was done for each sample and the transcript
values corresponding to the linear part of the amplification
curve were used to quantitate the messages versus the
GAPDH signal determined in the same way.The procedure
was repeated on three different experiments, with always
the same finding.Discussion
We used a lipopolysaccharide (LPS) model of chondro-
cyte activation to determine the respective role of NO and
ROS on the expression of TGF- and its receptors. Pre-
vious studies have shown that LPS can induce the produc-
tion by chondrocytes of NO and ROS including H2O2, O−2
and °OH38,39. A first basic information can be drawn fromTable I
Nucleotide sequences of RT-PCR primer pairs (5′—3′ orientation)
TGF-1
Sense 5′-GCCCTGGACACCAACTATTGC-3′
Antisense 5′-GCTGCACTTGCAGGAGCGCAC-3′
TGF-2
Sense 5′-GCTTTGGATGCGGCCTATTGC-3′
Antisense 5′-GCTGCATTTGCAAGACTTTAC-3′
TGF-3
Sense 5′-ACACCAATTACTGCTTCCGC-3′
Antisense 5′-GGAGGACCCCCAAAGTGGAG-3′
Type I TGF- receptor
Sense 5′-ATTGCTGGACCAGTGTGCTTCGTC-3′
Antisense 5′-TAAGTCTGCAATACAGCAAGTTCCATTCTT-3′
Type II TGF- receptor
Sense 5′-CGCTTTGCTGAGGTCTATAAGGCC-3′
Antisense 5′-GATATTGGAGCTCTTGAGGTCCCT-3′
GAPDH
Sense 5′-TGGTATCGTGGAAGGACTCATGAC-3′
Antisense 5′-ATGCCAGTGAGCTTCCCGTTCAGC-3′Results
BLOCKADE OF ROS FORMATION STIMULATES LPS-INDUCED NO
PRODUCTION IN ARTICULAR CHONDROCYTES
Human articular chondrocytes cultured in suspension
produced very low levels of NO, in the present experimen-
tal conditions [Fig. 1(a)]. However in the presence of LPS
(10 g/ml) for 48 h, the cells were strongly stimulated and
released high levels of nitric oxide (about 14 times more).
As expected, this effect was completely abolished in the
presence of L-NMMA (0.5 mM), an inhibitor of iNOS
enzyme activity. In contrast, NAC (1 mM) which is known
as a molecule neutralizing ROS formation, was capable of
stimulating NO production in both basal and LPS-treatment
conditions. Furthermore, the results constantly showed a
synergistic effect of this compound on LPS action [almost
double value; compare bar 6 to bar 2 in Fig. 1(a)], suggest-
ing that blockade of ROS formation may reinforce the
activity of the NO metabolic pathway.
The effect of LPS on NO production was mirrored at the
level of iNOS mRNA steady-state levels which were
increased by approximately 8 folds [Fig. 1(b)]. This action
was not modified in the presence of L-NMMA, confirmingthat the inhibitor has no effect on transcriptional activity of
iNOS gene. Interestingly enough, addition of NAC to the
cultures induced an elevation of iNOS messenger amount
comparable to that elicited by LPS treatment. However,
there was no apparent synergism with LPS at the level of
mRNA values, contrasting with the findings on NO produc-
tion [Fig. 1(b)]. These data support the hypothesis that the
co-operation between NAC and LPS in NO formation is
exerted on the iNOS enzyme activity rather than on the
transcriptional level of the gene.NO AND ROS DIFFERENTIALLY CONTROL THE EXPRESSION OF
TGF-S
TGF-s are know to counteract several deleterious
effects of IL-1 in several tissues, including cartilage. There-
fore, it was of interest to estimate the expression level of
the three representative members of this family in articular
chondrocytes upon LPS-induced production of NO and
ROS. As can be seen in Fig. 2(a), the steady-state levels of
TGF-1 mRNA were significantly decreased in the pres-
ence of L-NMMA in both control and LPS-treated cultures,
indicating that NO positively controls the transcriptional
activity of TGF-1 gene. In contrast, no significant effect
was observed when cells were exposed to NAC, an
inhibitor of ROS production. This finding suggests that
the maintenance of basal TGF-1 expression is
NO-dependent, at least in our experimental conditions.
TGF-2 mRNA levels were found to be differentially modu-
lated, as LPS alone could induce a significant reduction of
the messenger which was not further changed in the
presence of NO inhibitor [Fig. 2(b)]. On the other hand,
ROS inhibition by NAC fully reversed the LPS inhibitory
effect. This apparent co-operation of LPS and NAC sug-
gests that ROS are involved in LPS-induced inhibition of
TGF-2 expression. In what concerns TGF-3, its expres-
sion was found to be markedly depressed in cultures
exposed to LPS but, in contrast to the TGF-1 and 2
isoforms, no effect of both L-NMMA and NAC was observed
[Fig. 2(c)]. These data clearly indicate that the down-
regulation of TGF-3 expression by LPS is likely to be
independent of NO and ROS levels.NO AND ROS UP-REGULATE TGF- RECEPTOR II EXPRESSION
Despite the fact that LPS treatment did not induce
significant variation in the steady-state levels of mRNA
encoding TGF- receptors I and II, we found a slight
elevation for TGF- receptor I and a clear reduction for
receptor II mRNA in the presence of either L-NMMA or NAC
[Fig. 3(a),(b)]. In the case of TGF- receptor II, it is worth
mentioning that the inhibitors are already effective in the
absence of LPS [Fig. 3(b)]. These data support the hypoth-
esis that the presence of some level of NO and ROS may
partially contribute to stimulate the expression of TGF-
receptor II.
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positive effect on NO production, already in the absence of
LPS activation. This effect was shown to reinforce the
stimulative action of LPS on NO synthesis, probably by
mechanisms which not only involve transcriptional control
but other steps, including possible increase of the enzyme
activity itself, since no significant change in iNOS mRNA
steady-state levels was found between LPS-activated
chondrocytes in the absence or presence of the antioxidant
N-acetyl-cysteine (NAC). It is worth mentioning that similar
findings have been reported in the case of IL-1 activation,
showing that NAC facilitated the cytokine-induced iNOS
expression in rat vascular smooth muscle through a
reduction/oxidation mechanism potentiating the p44/42
MAPK signalling pathway46. As an explanation of this
interaction between ROS and NO pathways, it can besuggested that ROS produced intracellularly in response to
LPS may react with NO to form peroxynitrite (ONOO−),
which is considered as a potential enzyme inactivator. In
the absence of ROS, this negative effect could be
cancelled, resulting in iNOS induction. However, the
mechanisms underlying these findings remain to be experi-
mentally elucidated. Since the effect observed here was
obtained with the antioxidant NAC, it would be particularly
interesting to determine if it is specific to this molecule or if
similar results could be obtained with other reductant
compounds. Indeed, NAC has been shown to suppress
nerve growth factor (NGF)-induced activation of AP-1 tran-
scription factor by uncoupling the upstream signal trans-
duction from RAS to the MAP kinase cascade in PC12
cells47 and the inhibitory effect of NAC in that case is
unlikely to be due to the suppression of ROS, becauseFig. 1. NO2/NO3 production and iNOS mRNA levels in LPS-treated human chondrocytes. Human chondrocytes were cultured for 48 h in the
absence or in the presence of LPS (10 g/ml), L-NMMA (0.5 mM) and NAC (1 mM). At the end of incubation, the media were harvested and
NO2/NO3 levels were determined. Total RNA was extracted from the cells, as described in Materials and methods and used for RT-PCR
assay of iNOS and GAPDH mRNA steady-state levels. The ratio of iNOS mRNA level to that of the house-keeping gene GAPDH was
established from the densitometric values of transcript scanning, using results within the linear part of amplification (22, 26, 29, 32 cycles for
iNOS and 20, 23, 26, 29 cycles for GAPDH). Results are expressed as mean±S.D. Comparison of mean values was performed using the
Student’s t-test. Drug treated groups are significantly different from the untreated groups: ***P<0.001.
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cells. Whatever mechanisms are responsible for the induc-
tion of iNOS expression in chondrocytes under ROS block-
ade, this effect must be taken into consideration when
therapeutic approaches of OA based on ROS inhibition are
envisaged.Contrasting with the previously reported inhibition
exerted on TGF-1 expression by IL-1-induced NO44, LPS-
induced NO in our model does not produce the same effect
on TGF-1 mRNA levels. First, LPS treatment did not
significantly alter TGF-1 mRNA level. Secondly, the NO
inhibitor L-NMMA caused a decrease of these levels in theFig. 2. Effect of L-NMMA and NAC on the expression of the three isoforms of TGF- in LPS-treated human chondrocytes. RT-PCR was
performed in the same conditions as in Fig. 1 and PCR products were analysed in a 2% gel agarose.
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suggesting that in our model some level of NO is required
for maintenance of TGF-1 expression. It is not surprising
that the effects of NO observed in our model, using LPS as
an activator of chondrocytes instead of IL-1, could be
different, since it is likely that the action of intracellular NO
is dependent on the cross-talks it may establish with the
other signaling pathways elicited either by LPS or IL-1. This
interpretation is also supported by the fact that NO pro-
duced by addition of exogeneous donor such as SNAP(S-nitroso-N-acetylpenicillamide) did not produce the same
effect as IL-1 in the study by Studer et al.44. TGF-2
expression in LPS-treated chondrocytes was found here to
be differentially controlled, compared to TGF-1. Activation
of the cells resulted in a significant reduction of TGF-2
mRNA steady-state levels which was not dependent on
NO. On the other hand, the expression of TGF-2 was
clearly enhanced when the production of other ROS was
suppressed, indicating that some ROS normally exert a
down-regulation on TGF-2 expression. Finally, TGF-3Table II
Summary of the potential effects of NO and ROS on the expression of TGF- and its receptors in cultured human
chondrocytes
LPS
(10 g/ml)
Blockade of NO
production by L-NMMA
(0.5 mM)
Blockade of ROS
production by NAC
(1 mM)
TGF-1 = & = Influence of NO
TGF-2 & & # Influence of ROS
TGF-3 & & & No apparent influence
TGF- RI = # # Influence of NO and ROS
TGF- RII = & & Influence of NO and ROSFig. 3. Effect of L-NMMA and NAC on the expression of TGF- receptors in LPS-treated human chondrocytes. RT-PCR was performed in
the same conditions as in Fig. 1 and PCR products analysed in the same conditions as for other messengers.
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LPS but no dependence towards NO or ROS production
could be established in the present study.
A definition of how NO and ROS could differentially
influence the expression of the three TGF- isoforms in
these experiments remains speculative because the
mechanisms that are involved in the control of TGF- gene
promoters are not completely understood. However, it is
known that TGF-1 promoter structure differs from that of
the two other isoforms by several characteristics. It con-
tains regulatory sequences, such as AP-1 binding sites and
several GC-rich zones which can bind Sp-1-like transcrip-
tion factors, but lacks TATA and CAAT boxes48. On the
other hand, TGF-2 and TGF-3 promoters present
respectively two and one TATA boxes. They contain CRE
(cAMP responsive elements)49,50 but whereas an AP-1 site
is present in TGF-2 gene, it is not functional, and TGF-3
promoter does not contain this later. Sp-1 seems to be
implicated in TGF-3 but not TGF-2 expression51. The
specific features of TGF-1 promoter probably explain that
this isoform has been given the most prominent role in the
early events of tissue remodeling, such as wound healing,
where its particular sensitivity to cytokine regulation has
been demonstrated. In this regard, it is interesting to note
that in our model NO was found to be required for its basal
expression. We may speculate that the NO produced
during the early lesion of cartilage could induce a positive
feed-back on TGF-1 expression as a beneficial repair
reaction. Despite the fact that TGF-2 is weakly expressed
in articular cartilage52, it may have some important role in
osteoarthritic tissue. However, it is difficult to determine
what could be the importance of the ROS-induced negative
control observed here on TGF-2 isoform in the context of
cartilage physiopathology. In what concerns TGF-3, which
is expressed at relative high amount in cartilage, it is clear
that activation of chondrocytes by LPS results in reduction
of this isoform expression but the mechanism is not
dependent on NO and ROS production.
Interestingly, we observed that the expression of TGF-
receptor II was positively controlled by NO and ROS levels.
We have previously reported that the response of cultured
chondrocytes to TGF- was dependent on the ratio
between TGF- receptor I and receptor II levels, this later
varying according to the cell proliferation state11. Further-
more, we have demonstrated in the OA rabbit model that
the expression of TGF- receptor II, the one which binds
the ligand, disappears almost totally in heavily degraded
cartilage, suggesting that the chondrocytes become insen-
titive to the growth factor and then cannot counteract
deleterious effects of IL-112. Therefore, NO and ROS
up-regulation of TGF- receptor II expression be con-
sidered as a beneficial feed-back mechanism elicited by
the deleterious cytokines, such as IL-1 and TNF-, in the
early steps of OA.
In summary, our findings suggest that the cellular redox
state regulates the cellular responses of chondrocytes in
concert with extracellular stimuli. It may be a significant
factor in altering the respective expression of the crucial
TGF- growth factor system, which is known to favor
cartilage repair. For example, excessive production of NO
and ROS observed in osteoarthritic joint tissues may serve
as a feed-back element to reduce IL-1 effects, through
stimulating TGF- receptor II expression, in a sort of ‘yin
yang’ mechanism. However, it is likely that the modulation
of these different genes is greatly dependent on the dosage
of the redox signal, which in turn is supposed to vary during
the course of the OA process. Therefore, both in vitro andReferences
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